JHIU
IART icon

Janus Henderson Investors US’s Integra LifeSciences IART Stock Holding History

Janus Henderson Investors US’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$88.8M Buy
2,107,875
+1,083,535
+106% +$46.3M 0.07% 312
2016
Q4 		$43.9M Buy
+1,024,340
New +$41.6M 0.04% 462

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Janus Henderson Investors US's IART Position: Q1 2017 in Review

Janus Henderson Investors US increased its Integra LifeSciences (IART) stake by 106% in Q1 2017, buying an estimated $46.3M and bringing the position to 2,107,875 shares worth $88.8M. The position accounts for 0.07% of the portfolio, ranked #312.

Janus Henderson Investors US first reported a position in IART in Q4 2016 and has held it in 2 quarters since. 236 funds tracked by Wall St. Rank hold IART as of Q1 2017.

  • Janus Henderson Investors US held 2,107,875 shares of Integra LifeSciences worth $88.8M as of Q1 2017.
  • Janus Henderson Investors US bought 1,083,535 Integra LifeSciences shares in Q1 2017, an estimated $46.3M.
  • Integra LifeSciences made up 0.07% of Janus Henderson Investors US's portfolio in Q1 2017, its #312 holding.
  • Janus Henderson Investors US first reported a position in Integra LifeSciences in Q4 2016 and has held it in 2 quarters since.
  • 236 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.